THANK YOU FOR SUBSCRIBING
With the help of new and expanded partnerships with leading health plans, the company has experienced significant growth
FREMONT, CA: Value-based kidney care company Somatus raised USD 64 million in a Series C funding round led by Longitude Capital and co-led by Optum Ventures and Deerfield Management Company. The round was participated by existing investors Blue Venture Fund, Flare Capital, and Town Hall Ventures. The new investment round takes the company's total raised capital to over USD 105 million.
“Since our inception, we have set out to do one thing: be the best provider of integrated care for those with or at risk of developing kidney disease,” said Somatus Co-Founder and CEO, Ikenna Okezie, MD. “Fueled by the tenacity of our team, the trust of our patients, and the support of our partners and investors, we have made great strides in the pursuit of our mission and helped spur needed transformation in the kidney care sector. This investment allows us to accelerate those efforts while solidifying ourselves as a preferred partner for health plans and a trusted advocate for patients.”
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
The completion of the Series C funding round marks yet another milestone for the company. With the help of new and expanded partnerships with leading health plans, the company has experienced significant growth. It now provides comprehensive and holistic kidney care services to more than 20,000 chronic kidney disease and end-stage kidney disease patients across six states.
“Somatus is at the forefront of revolutionary change in an industry that has forced patients to accept the status quo for far too long,” said Longitude Capital Managing Director, Gregory Grunberg, MD. “Somatus is transforming how the industry cares for patients with chronic kidney disease by not only meeting them where they are but also by aligning all kidney care stakeholders to support the health and wishes of patients. This patient-centric model is a win-win solution for patients, partners, and providers.”
The company's proceeds from the investment round will be used to scale its model nationally and invest in technology and product development to better support patients and health plan partners. “Somatus’ team-based management of kidney disease ensures people get the expert, engaged, compassionate care they need and deserve, more affordably,” said Larry C. Renfro, managing partner of Optum Ventures. “This progressive approach to treating chronic disease is increasingly important for health care payers and care providers who are dedicated to achieving better health outcomes for the patients and populations they serve.”
See Also: Top Healthcare Consulting/Services Companies
More in News